GlobeNewswire Clinical StudiesOriginal article
Spryte Medical Completes INSYTE Trial Enrollment
Trial StartnOCT™ Imaging SystemPositive
AI Analysis
Summary
Spryte Medical has completed enrollment in the FDA-approved INSYTE IDE trial of its nOCT Imaging System for intracranial aneurysm diagnosis. Enrollment completion represents progress toward regulatory submission for diagnostic use.
Clinical Trial Data
Outcome Details
INSYTE trial enrollment completed
Importance:5/10
Sentiment:
0.60
FDA IDE approvaldiagnostic imagingintracranial aneurysmtrial enrollment completionregulatory pathway
Related Companies
Read the original article
Published by GlobeNewswire Clinical Studies on July 22, 2026 4:12 PM